Stay updated with breaking news from Sheet Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Caladrius Biosciences, Inc. , a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease, provides a business update and... | March 22, 2022
Net earnings were $746.4 million, or $0.70 per diluted share for the third quarter of fiscal 2022 compared with $607.5 million, or $0.55 per diluted share for...
Net earnings were $746.4 million, or $0.70 per diluted share for the third quarter of fiscal 2022 compared with $607.5 million, or $0.55 per diluted share for...
/PRNewswire/ -- Explanatory Note On January 28, 2022, Touchstone Bankshares, Inc. (the "Company") issued a press release reporting its preliminary financial...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.